Cargando…
Societal costs of non-cardiac chest pain compared with ischemic heart disease - a longitudinal study
BACKGROUND: Non-cardiac chest pain (NCCP) is a common complaint. Our aim was to present a detailed description of the costs of patients with NCCP compared to patients with acute myocardial infarction (AMI) and Angina Pectoris (AP) from a societal perspective. METHODS: Data on healthcare utilization...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851841/ https://www.ncbi.nlm.nih.gov/pubmed/24107009 http://dx.doi.org/10.1186/1472-6963-13-403 |
_version_ | 1782294364845768704 |
---|---|
author | Mourad, Ghassan Alwin, Jenny Strömberg, Anna Jaarsma, Tiny |
author_facet | Mourad, Ghassan Alwin, Jenny Strömberg, Anna Jaarsma, Tiny |
author_sort | Mourad, Ghassan |
collection | PubMed |
description | BACKGROUND: Non-cardiac chest pain (NCCP) is a common complaint. Our aim was to present a detailed description of the costs of patients with NCCP compared to patients with acute myocardial infarction (AMI) and Angina Pectoris (AP) from a societal perspective. METHODS: Data on healthcare utilization and annual societal costs, including direct healthcare costs and indirect costs due to productivity loss, were collected from different databases. The participants consisted of 199 patients from a general hospital in Sweden (99 with NCCP, 51 with AMI, 49 with AP), mean age of 67 years, 59% men. RESULTS: NCCP, AMI, and AP patients had on average 54, 50 and 65 primary care contacts and 3, 4, and 4 hospital admissions during a period of 2 years. Length of hospital stay was 6, 11 and 11 days. On average, 14%, 18%, and 25% of NCCP, AMI and AP patients were on sick-leave annually, and about 12% in each group received a disability pension. The mean annual societal costs of NCCP, AMI and AP patients were €10,068, €15,989 and €14,737. CONCLUSIONS: Although the annual societal cost of NCCP patients was lower than in AMI and AP patients, the cost was still considerable (€10,068). Taken into account the high prevalence of NCCP, the cumulative annual national cost of these patients could be more than the double of AMI and AP if all patients incurred the same costs as in this study. Targeted interventions are important in order to support patients with NCCP and minimize healthcare utilization and costs. |
format | Online Article Text |
id | pubmed-3851841 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-38518412013-12-06 Societal costs of non-cardiac chest pain compared with ischemic heart disease - a longitudinal study Mourad, Ghassan Alwin, Jenny Strömberg, Anna Jaarsma, Tiny BMC Health Serv Res Research Article BACKGROUND: Non-cardiac chest pain (NCCP) is a common complaint. Our aim was to present a detailed description of the costs of patients with NCCP compared to patients with acute myocardial infarction (AMI) and Angina Pectoris (AP) from a societal perspective. METHODS: Data on healthcare utilization and annual societal costs, including direct healthcare costs and indirect costs due to productivity loss, were collected from different databases. The participants consisted of 199 patients from a general hospital in Sweden (99 with NCCP, 51 with AMI, 49 with AP), mean age of 67 years, 59% men. RESULTS: NCCP, AMI, and AP patients had on average 54, 50 and 65 primary care contacts and 3, 4, and 4 hospital admissions during a period of 2 years. Length of hospital stay was 6, 11 and 11 days. On average, 14%, 18%, and 25% of NCCP, AMI and AP patients were on sick-leave annually, and about 12% in each group received a disability pension. The mean annual societal costs of NCCP, AMI and AP patients were €10,068, €15,989 and €14,737. CONCLUSIONS: Although the annual societal cost of NCCP patients was lower than in AMI and AP patients, the cost was still considerable (€10,068). Taken into account the high prevalence of NCCP, the cumulative annual national cost of these patients could be more than the double of AMI and AP if all patients incurred the same costs as in this study. Targeted interventions are important in order to support patients with NCCP and minimize healthcare utilization and costs. BioMed Central 2013-10-09 /pmc/articles/PMC3851841/ /pubmed/24107009 http://dx.doi.org/10.1186/1472-6963-13-403 Text en Copyright © 2013 Mourad et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Mourad, Ghassan Alwin, Jenny Strömberg, Anna Jaarsma, Tiny Societal costs of non-cardiac chest pain compared with ischemic heart disease - a longitudinal study |
title | Societal costs of non-cardiac chest pain compared with ischemic heart disease - a longitudinal study |
title_full | Societal costs of non-cardiac chest pain compared with ischemic heart disease - a longitudinal study |
title_fullStr | Societal costs of non-cardiac chest pain compared with ischemic heart disease - a longitudinal study |
title_full_unstemmed | Societal costs of non-cardiac chest pain compared with ischemic heart disease - a longitudinal study |
title_short | Societal costs of non-cardiac chest pain compared with ischemic heart disease - a longitudinal study |
title_sort | societal costs of non-cardiac chest pain compared with ischemic heart disease - a longitudinal study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851841/ https://www.ncbi.nlm.nih.gov/pubmed/24107009 http://dx.doi.org/10.1186/1472-6963-13-403 |
work_keys_str_mv | AT mouradghassan societalcostsofnoncardiacchestpaincomparedwithischemicheartdiseasealongitudinalstudy AT alwinjenny societalcostsofnoncardiacchestpaincomparedwithischemicheartdiseasealongitudinalstudy AT stromberganna societalcostsofnoncardiacchestpaincomparedwithischemicheartdiseasealongitudinalstudy AT jaarsmatiny societalcostsofnoncardiacchestpaincomparedwithischemicheartdiseasealongitudinalstudy |